Proteases
-   A4063 MPC-3100Summary: Hsp90 inhibitor A4063 MPC-3100Summary: Hsp90 inhibitor
-   A4024 Danoprevir (RG7227)Target: HCV ProteasesSummary: HCV NS3/4A protease inhibitor A4024 Danoprevir (RG7227)Target: HCV ProteasesSummary: HCV NS3/4A protease inhibitor
-   A8204 LopinavirSummary: HIV protease inhibitor,highly potent A8204 LopinavirSummary: HIV protease inhibitor,highly potent
-   A4341 ApixabanSummary: Factor Xa inhibitor A4341 ApixabanSummary: Factor Xa inhibitor
-   A1930 M50054Summary: Associate with caspase-3 inhibition A1930 M50054Summary: Associate with caspase-3 inhibition
-   A4400 BMS 299897Summary: γ--secretase inhibitor, potent and orally active A4400 BMS 299897Summary: γ--secretase inhibitor, potent and orally active
-   A4434 CL 82198 hydrochlorideSummary: Selective MMP-13 inhibitor A4434 CL 82198 hydrochlorideSummary: Selective MMP-13 inhibitor
-   A8566 GSK744 (S/GSK1265744)Summary: HIV integrase inhibitor, oral active and long-acting A8566 GSK744 (S/GSK1265744)Summary: HIV integrase inhibitor, oral active and long-acting
-   B5780 UAMC 00039 dihydrochlorideTarget: Dipeptidyl-peptidase IISummary: dipeptidyl peptidase II (DPP-II) inhibitor B5780 UAMC 00039 dihydrochlorideTarget: Dipeptidyl-peptidase IISummary: dipeptidyl peptidase II (DPP-II) inhibitor
-   C3609 (Z-Ala-Ala-Ala-Ala)2Rh110Summary: fluorogenic elastase substrate C3609 (Z-Ala-Ala-Ala-Ala)2Rh110Summary: fluorogenic elastase substrate
